Litcius/Paper detail

Clinical Development of BRAF plus MEK Inhibitor Combinations

Vivek Subbiah, Christina S. Baik, John M. Kirkwood

2020Trends in cancer353 citationsDOIOpen Access PDF

Topics & Concepts

MEK inhibitorCancer researchChemistryPharmacologyMedicineMAPK/ERK pathwayPhosphorylationBiochemistryMelanoma and MAPK PathwaysCytokine Signaling Pathways and InteractionsCancer Mechanisms and Therapy
Clinical Development of BRAF plus MEK Inhibitor Combinations | Litcius